Treatment of Angina Pectoris and Coronary Insufficiency

1961 ◽  
Vol 45 (6) ◽  
pp. 1409-1414
Author(s):  
Willlam L. Proudfit
2019 ◽  
Vol 9 (3) ◽  
pp. 197-206
Author(s):  
Kanika Patel ◽  
Mahfoozur Rahman ◽  
Vikas Kumar ◽  
Amita Verma ◽  
Dinesh Kumar Patel

Background: Ammi visnaga commonly known as ‘honey plant, tooth pick fruit, bisnaga and khella’ is an important plant of Apiaceae family. It is an annual herb found in Europe, Asia, North Africa, Latin America and in India. Carrot, parsnip, celery, coriander, anise, caraway, cumin, parsley and dill are some other plants of the same family i.e., ‘Apiaceae’. Fruits of Ammi visnaga (A. visnaga) are medicinally used as a strong photosensitizer, diaphoretic, carminative and antispasmodic agents. Objective: A. visnaga has been used for the treatment of bronchial asthma, coronary insufficiency, angina pectoris, psoriasis, renal colic and ureteric stones. Visnagin (C13H10O4) is a ‘furanochromone derivative’ which is the main active constituent’s of A. visnaga. Visnagin is used for the treatment of low blood-pressure, angina pectoris and kidney stone. It also has neuroprotective and antiinflammatory activity. Moreover, visnagin also treat whooping cough, ureter and bile duct, gall bladder and renal colic, tumors and epileptic seizures. Methods: This review summarizes data’s regarding the biological importance, pharmacological uses and medicinal importance of A. visnaga and their important active constituent’s “visnagin”. Moreover, the detailed pharmacological aspects of visnagin were presented in this review. Further various analytical techniques used for the extraction and isolation of visnagin were also discussed. Studies related to the pharmacological profile of the plants and their active phytoconstituents are one of the leading areas of research. Conclusion: This review will be beneficial to the scientific society to understand the importance of A. visnaga plant and their active constituents ‘visnagin’for the development of alternative tools to treat disorders in the future.


2017 ◽  
Vol 02 (04) ◽  
pp. 094-098
Author(s):  
Meenakshi Kadiyala ◽  
Rameshwar Roopchandar ◽  
Chandrshekaran Krishnaswamy

AbstractBecause of improvement in survival from coronary artery disease and increasing life expectancy of the population, chronicity and resistance to therapy have become growing problems confronting the cardiologist. Refractory angina pectoris is an entity based on clinical diagnosis, and it refers to recurrent and sustained chest pain more than 3 months duration caused by coronary insufficiency that is unamenable to conventional modalities of treatment, including drugs, percutaneous coronary interventions, or coronary bypass grafting. Individuals with this entity may have an impaired quality of life, with recurrent angina, poor general health and psychological distress impairing functional and productive sustenance. A multitude of therapeutic options exists for patients with refractory angina pectoris, and randomized trials have shown them to be reasonably effective in reducing symptoms, though further research is warranted.


1944 ◽  
Vol 27 (6) ◽  
pp. 803-816 ◽  
Author(s):  
Arthur M. Master ◽  
Harry L. Jaffe ◽  
Simon Dack ◽  
Arthur Grishman

Circulation ◽  
1972 ◽  
Vol 45 (4) ◽  
pp. 837-844 ◽  
Author(s):  
MATIJA HORVAT ◽  
SHINJI YOSHIDA ◽  
RAVI PRAKASH ◽  
HAROLD S. MARCUS ◽  
H. J.C. SWAN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document